Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging
Advances in intravascular imaging have permitted comprehensive evaluation of coronary atherosclerotic plaque from the perspective of its burden and individual components. These advances have been integrated in clinical trials that have evaluated the impact of intensive lipid lowering regimens. These...
Saved in:
Main Authors: | Giuseppe Di Giovanni (Author), Stephen J Nicholls (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015) -
Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015) -
Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet?
by: Pamela Piña, et al.
Published: (2023) -
Lipid lowering combination therapy: From prevention to atherosclerosis plaque treatment
by: Lluís Masana, et al.
Published: (2023) -
Progression of coronary atherosclerosis in patients without standard modifiable risk factors
by: Jawad Mazhar, et al.
Published: (2020)